Evidence map›Paper›PMID 21289286›Full record

ArticleAmerican journal of physiology. Cell physiology2011

S1P₂ receptor regulation of sphingosine-1-phosphate effects on conventional outflow physiology.

Grant M Sumida, W Daniel Stamer

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Inflammatory Ocular Diseases and Sphingolipid Signaling.Advances in experimental medicine and biology · 2019
    Review
  7. Article
  8. Gene transfer to the outflow tract.Experimental eye research · 2017
    Review
  9. Article
  10. Article
  11. Physical Factors Affecting Outflow Facility Measurements in Mice.Investigative ophthalmology & visual science · 2015
    Article
  12. Role of nitric oxide in murine conventional outflow physiology.American journal of physiology. Cell physiology · 2015
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. eNOS, a pressure-dependent regulator of intraocular pressure.Investigative ophthalmology & visual science · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Grant M SumidaDept. of Ophthalmology and Vision Science, University of Arizona, 655 North Alvernon Way, Tucson, AZ 85711, USA.
W Daniel Stamer
University of Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Elevated intraocular pressure is the main risk factor in primary open-angle glaucoma, involving an increased resistance to aqueous humor outflow in the juxtacanalicular region of the conventional outflow pathway which includes the trabecular meshwork (TM) and the inner wall of Schlemm's canal (SC). Previously, sphingosine-1-phosphate (S1P) was shown to decrease outflow facility in porcine and human eyes, thus increasing outflow resistance and intraocular pressure. Owing to S1P's known effect of increasing barrier function in endothelial cells and the robust expression of the S1P₁ receptor on the inner wall of SC, we hypothesized that S1P₁ receptor activation promotes junction formation and decreases outflow facility. The effects of subtype-specific S1P receptor compounds were tested in human and porcine whole-eye perfusions and human primary cultures of SC and TM cells to determine the receptor responsible for S1P effects on outflow resistance. The S1P₁-specific agonist SEW2871 failed to both mimic S1P effects in paired human eye perfusions, as well as increase myosin light chain (MLC) phosphorylation in cell culture, a prominent outcome in S1P-treated SC and TM cells. In contrast, the S1P₂ antagonist JTE-013, but not the S1P₁ or S1P₁,₃ antagonists, blocked the S1P-promoted increase in MLC phosphorylation. Moreover, JTE-013 prevented S1P-induced decrease in outflow facility in perfused human eyes (P < 0.05, n = 6 pairs). Similarly, porcine eyes perfused with JTE-013 + S1P did not differ from eyes with JTE-013 alone (P = 0.53, n = 3). These results demonstrate that S1P₂ , and not S1P₁ or S1P₃, receptor activation increases conventional outflow resistance and is a potential target to regulate intraocular pressure.

Indexed as

AnimalsAqueous HumorCells, CulturedGlaucoma, Open-AngleHumansIntraocular PressureLysophospholipidsMyosin Light ChainsOxadiazolesPhosphorylationPyrazolesPyridinesReceptors, LysosphingolipidSphingosineSwineThiophenesJTE 013LysophospholipidsMyosin Light ChainsOxadiazolesPyrazolesPyridinesReceptors, LysosphingolipidSEW2871Sphingosinesphingosine 1-phosphateThiophenes

Identifiers

PMID21289286
PMCPMC3093947
OpenAlexW2121872311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.